Botulism: Update and review

Seminars in Neurology

Volumn 24, Issue 2, 2004, Pages 155-163

  Cherington, Michael ^a,b  

^a St Anthony Central Hospital   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Antitoxin; Botulinum toxin; Botulism; Electrodiagnosis; New forms; Paralysis

Indexed keywords

4 AMINOPYRIDINE; ACETYLCHOLINE; ANTITOXIN; BOTULINUM ANTISERUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULISM ANTISERUM; GUANIDINE DERIVATIVE; IMMUNOGLOBULIN; POLYVALENT ANTITOXIN; STEROID; UNCLASSIFIED DRUG;

ANUS FISSURE; BONE MARROW SUPPRESSION; BOTULISM; CLINICAL FEATURE; CLINICAL TRIAL; CLOSTRIDIUM BOTULINUM; CRANIAL NERVE PARALYSIS; DIFFERENTIAL DIAGNOSIS; DIPHTHERIA; DOSE TIME EFFECT RELATION; DRUG HYPERSENSITIVITY; DYSPHAGIA; DYSTONIA; EATON LAMBERT SYNDROME; ELECTRODIAGNOSIS; ESOPHAGUS ACHALASIA; FOOD CONTAMINATION; GUILLAIN BARRE SYNDROME; HIDDEN BOTULISM; HUMAN; INADVERTENT BOTULISM; INFANT BOTULISM; INFANT DISEASE; MIGRAINE; MOTOR DYSFUNCTION; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NEPHRITIS; NEUROLOGIC DISEASE; NEUROMUSCULAR JUNCTION DISORDER; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SEIZURE; SPASTICITY; STRABISMUS; TICK BITE; TREATMENT INDICATION; WOUND BOTULISM; WOUND INFECTION;

BOTULINUM TOXINS; BOTULISM; HUMANS;

EID: 3242762367     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830901     Document Type: Review

References (86)

1. Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998;21:701-710
2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 1980;17:21-25
3. Chang M, Glynn K, Groseclose SL. Endemic, notifiable bioterrorism-related diseases, Unites States 1992-1999. Emerg Infect Dis 2003;9:556-564
4. Han SZ, Alfano MC, Psoter WJ, Rekow ED. Bioterrorism and catastrophe response. J Am Dent Assoc 2003;134:745-752
5. Lamanna C. The most poisonous poison. Science 1959;130:763-772
6. Burningham MD, Walter FG, Mechem C, et al. Wound botulism. Ann Emerg Med 1994;24:1184-1187
7. Hughes JM. Botulism. In: Scheid WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. New York: Raven Press; 1991:150-153
8. Schantz EJ, Johnson EA. Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med 1997;40:317-327
9. Foran PG, Davletov B, Meunier FA. Getting muscles moving again after botulinum toxin: novel therapeutic challenges. Trends Mol Med 2003;9:291-298
10. Maselli RA. Pathogenesis of human botulism. Ann N Y Acad Sci 1998;841:122-139
11. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992;359:832-835
12. Barnes M. Botulinum toxin: mechanisms of action and clinical use in spasticity. J Rehabil Med 2003;41(suppl):56-59
13. Cherington M. Botulism: ten year experience. Arch Neurol 1974;30:432-437
14. Woodruff BA, Griffin PM, McCroskey LM, et al. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States 1975-1988. J Infect Dis 1992; 166:1281-1286
15. Beller M. Available at: www.phppo.cdc.gov/phtn/botulism/ alaska/alaska.asp. Accessed 2003
16. Townes JM, Cieslak PR, Hatheway CL, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med 1996;125:558-563
17. Shapiro RL, Hatheway C, Becher J, Swerdlow DL. Botulism surveillance and emergency response. JAMA 1997;278:433-435
18. Hayes MT, Soto O, Ruoff KL. Case records of the Massachusetts General Hospital: case 22-1997. N Engl J Med 1997;337:184-190
19. Angulo FJ, Getz J, Taylor JP, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998;178:172-177
20. Brown LW. Infant botulism. Adv Pediatr 1981;28:141-157
21. Goode GB, Shearn DL. Botulism. A case with associated sensory abnormalities. Arch Neurol 1982;39:55
22. Kuruoglu R, Cengiz B, Tokcaer A. Botulism with sensory symptoms diagnosed by neuromuscular transmission studies associated with edrophonium responsiveness. Electromyogr Clin Neurophysiol 1996;36:477-480
23. Martinez-Castrillo JD, Del Real MA, Hernandex Gonzalez A, et al. Botulism with sensory symptoms: a second case. J Neurol Neurosurg Psychiatry 1991;54:844-845
24. Girlanda P, Vita G, Nicolosi C, et al. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992;55:844-845
25. Jenzer G, Mumenthaler M, Ludin HP, Robert F. Autonomic dysfunction in botulism B: a clinical report. Neurology 1975; 25:150-153
26. Chen JT, Chen CC, Lin KP, et al. Botulism: heart rate variation, sympathetic skin responses, and plasma norepinephrine. Can J Neurol Sci 1999;26:123-126
27. Duchen LW, Strich SJ. The effects of botulism toxin on the pattern of innervation of skeletal muscle in the mouse. QJ Exp Physiol Cogn Med Sci 1968;53:84-89
28. Eleopra R, Tugnoli V, Rossetto O, et al. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 1998;256:135-138
29. Uncini A, Lugarosi A. Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 1999;22:640-644
30. Shapiro BE, Soto O, Shafqat S, Blumenfeld H. Adult botulism. Muscle Nerve 1997;20:100-102
31. Cherington M. Electrophysiologic methods as an aid in diagnosis of botulism: a review. Muscle Nerve 1982;5:S28-S29
32. Ryan DW, Cherington M. Human type A botulism. JAMA 1971;216:513-514
33. Edell TA, Sullivan CP, Osborn KM, et al. Wound botulism associated with a positive tensilon test. West J Med 1983;139:218-219
34. Pickett JB, Berg B, Chaplin E, Brunstetter-Shafer MA. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 1976;295:770-772
35. Arnon SS. Infant botulism: anticipating the second decade. J Infect Dis 1986;154:201-205
36. Schmidt RD, Schmidt TW. Infant botulism: a case series and review of the literature. J Emerg Med 1992;10:713-718
37. Kothare SV, Kassner EG. Infant botulism: a rare cause of colonic ileus. Pediatr Radiol 1995;25:24-26
38. Tanki MG, Gabay MP. Association between honey consumption and infant botulism. Pharmacotherapy 2002;22:1479-1483
39. Ravid S, Maytal J, Eviatar L. Biphasic course of infant botulism. Pediatr Neurol 2000;23:338-340
40. Schechter R. Infant botulism: a brief overview. Anaerobe 1999;5:161-164
41. Underwook K, Deakers TW, Newth CJ, Mitchell WG. Infant botulism: a 26-year experience in the pediatric intensive care unit. Crit Care Med 2003;31(suppl):Abstract 531
42. Bennett AM, Perkins SD, Holley JL. DNA vaccination protects against botulinum neurotoxin F. Vaccine 2003;21:3110-3117
43. Midura TF. Update: infant botulism. Clin Microbiol Rev 1996;9:119-125
44. Armada M, Love S, Barrett E, et al. Foodborne botulism in a six-month old infant caused by home-canned baby food. Ann Emerg Med 2003;42(2):226-229
45. MacDonald KL, Rutherford GW, Friedman SM, et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med 1985;102:616-618
46. Mandler RN, Maselli RA. Stimulated single-fiber electromyography in wound botulism. Muscle Nerve 1996;19:1171-1173
47. Chang GY, Ganguly G. Early antitoxin treatment in wound botulism results in better outcome. Eur Neurol 2003;49:151-153
48. Kudrow DB, Henry DA, Haska DA, et al. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse. Ann Intern Med 1988;109:984-985
49. Cherington M. Treatment of botulism and wound botulism. In: Balows A, DeHaan RM, Dowell VR, Guze LB, eds. Anaerobic Bacteria: Role in Disease. Springfield: Charles C. Thomas; 1974:287-294
50. Park J-B, Simpson LL. Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infect Immun 2003;71:1147-1154
51. Cherington M. Botulism. Semin Neurol 1990;10:27-31
52. Technical Briefs. Botulism: information from the World Health Organization. J Environ Health 2003;65:51-52
53. Chia JK, Clark JG, Ryan CA, Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med 1986;315:239-241
54. Kobayashi H, Fujisawa K, Saito Y, et al. A botulism case of a 12-year-old girl caused by intestinal colonization of Clostridium botulinum type Ab. Jpn J Infect Dis 2003;56:73-74
55. Bakheit AM, Ward CD, McLellan DL. Generalised botulism-like syndrome after intramuscular injections of botulinum type A: a report of two cases. J Neurol Neurosurg Psychiatry 1997;62:198
56. Bhatia KP, Munchau A, Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases. J Neurol Neurosurg Psychiatry 1999;67:90-93
57. Tugnoli V, Eleopra R, Quatrale R, et al. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol 2002;147:808-809
58. Girlanda P, Vita G, Nicolosi C, et al. Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992;55:844-845
59. Lange DJ, Brin MF, Warner CL, et al. Distant effects of local injection of botulinum toxin. Muscle Nerve 1987;10:552-555
60. Olney RK, Aminoff MJ, Gelb DJ, Lowenstein DH. Neuromuscular effects distant from the site of botulinum neurotoxin injections. Neurology 1988;38:1780-1783
61. Kessler KR, Skutta M, Benecke R. Long term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. J Neurol 1999;246:265-274
62. Ross MH, Charness ME, Sudarsky L, Logigian EL. Treatment of occupational cramp with botulinum toxin: diffusion of toxin to adjacent noninjected muscles. Muscle Nerve 1997; 20:593-598
63. Dressler D, Benecke R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 2003;49:34-38
64. Dowell VR, McCrosky LM, Hatheway CL, et al. Coproexamination for botulium toxin and Clostridium botulinum. JAMA 1977;238:1829-1832
65. Cornblath DR, Sladky JT, Sumner AJ. Clinical electrophysiology of infantile botulism. Muscle Nerve 1983;6:448-452
66. Gutmann L, Bodensteiner J, Gutierrez A. Electrodiagnosis of botulism. J Pediatr 1992;121:835
67. Fakadej AV, Gutmann L. Prolongation of post-tetanic facilitation in infant botulism. Muscle Nerve 1982;5:727-729
68. Girlanda P, Dattola R, Messina C. Single fibre EMG in 6 cases of botulism. Acta Neurol Scand 1983;67:118-123
69. Schiller HH, Stalberg E. Human botulism studied with single-fiber electromyography. Arch Neurol 1978;35:346-349
70. Hughes JM, Tacket CO. "Sausage poisoning" revisited. Arch Intern Med 1983;143:425-427
71. Atabek ME, Yavuz H, Oran B, et al. Plasmapheresis as an adjunct treatment in severe botulism. Intensive Care Med 2002;28:814
72. Robinson RF. Management of botulism. Ann Pharmacother 2003;37:127-131
73. Vahdani P, Pourshafie MR, Aminzadeh Z. Treatment of two unusual cases of type A and E botulism following consumption of salted fish. Intensive Care Med 2002;28:1189
74. Amersdorfer P, Wong C, Smith T, et al. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Vaccine 2002;20:1640-1648
75. Nowakowski A, Wang C, Powers DB, et al. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci USA 2002;99:11346-11350
76. Cherington M. Botulism. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, eds. Neuromuscular Disorders in Clinical Practice. Boston: Butterworth Heinemann; 2002:942-952
77. Jankovic J, Vuong MA, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003;60:1186-1188
78. Dodick DW. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache 2003;43:S25-S33
79. Rohrich RJ. Completing the cosmetic surgery cycles: it takes a village. Plast Reconstr Surg 1999;103:585-587
80. Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomized trial. Gut 1999;44:231-239
81. Brisinda G, Maria G, Bentivoglo AR, et al. A comparison of injection of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999;341:65-69
82. Maria G, Brisinda G, Civello IM, et al. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 2003;62:259-265
83. Hallett M. One man's poison: clinical applications of botulinum toxin. N Engl J Med 1999;341:118-120
84. Eleopra R, Tugnoli V, Quatrale R, et al. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting. Clin Neurophysiol 2002;113:1258-1264
85. Brashear A, McAfee AL, Kuhn ER, Ambrosius WT. Treatment with botulinum toxin type B for upper-limb spasticity. Arch Phys Med Rehabil 2003;84:103-107
86. Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci 2002;27:552-558